N
Neurotron Biotechnology
Neurotron Biotechnology is a China-based medical device company developing spine-related products
About Neurotron Biotechnology
Neurotron Biotechnology, founded in 2006, is a medical device company focused on designing, developing, and marketing neurostimulation systems to address profound hearing loss. The company's main offering is the Venus Cochlear Implant System, a solution for both adults and children. This system represents a significant milestone as the first commercially available, affordable cochlear implant to provide high performance comparable to existing, more expensive devices.
The development of the Nurotron device was driven by the significant unmet need for affordable cochlear implants, particularly in low- and middle-income countries. In China alone, where the company is based, there are millions of individuals with deafness, but only a small fraction have received implants due to high costs. Neurotron successfully addressed this by drastically reducing the unit cost, making the technology more accessible. For instance, through the Chinese Government Tender Program, the price dropped from US$25,000 in 2011 to US$4,620 in 2017.
The company's Venus Cochlear Implant features a 22 mm electrode array with 24 intracochlear electrodes. It has received China FDA approval in 2011 and the European CE marking in 2012, and is also approved for sale in Colombia, India, Turkey, and Venezuela. While the company has a research and development center in Irvine, California, the Venus system is not yet FDA-approved for the U.S. market. Neurotron also manufactures its systems in a large complex in Zhejiang Hangzhou, China. Beyond cochlear implants, the company is also developing other neurostimulation solutions, including auditory brainstem implants, artificial vision systems, and treatments for paralysis.
Source: Dealroom company dataNews
Open roles
Neurotron Biotechnology in the Hangzhou ecosystem
The Neurotron Biotechnology office with the hot startups, most funded companies and investors around it. Hover or tap a pin.
Dealroom maps whole ecosystems like this one for cities, regions and governments. See the ecosystem platform →
Investors
From Dealroom's funding and investor records, grouped by the round each investor first entered.
Series B and later2 investors entered at this stage
Kleiner Perkins
Detong Capital
Source: Dealroom Talent Intelligence.
Global footprint
team presence
Market sentiment
An AI-synthesised read of the highest-engagement posts about Neurotron Biotechnology on X, ranked by likes and reposts, corporate channels excluded.
Reading the room on X — pulling top posts and synthesizing themes…
Source: X recent search ranked by engagement (likes + retweets) · Synthesis by Claude · Cached for 1 hour
See Neurotron Biotechnology on the full Dealroom platform
Live deal flow, founder pedigree, hiring signals, revenue trajectory, and the full cap table.